Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma

Overview of attention for article published in Frontiers in immunology, April 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 34,410 followers.

RT @FrontImmunol: New Research: Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells…

15 May 2021

Reply Repost Favourite

New Research: Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma: Background Less than 20% of melanoma patients respond to programmed cell death-1 (PD-1) blockade… https://t.co/soedMt4Etm

15 May 2021

Reply Repost Favourite

RT @MelanRes_papers: Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma…

05 May 2021

Reply Repost Favourite

Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma https://t.co/5bZAx93avz

04 May 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.